Clinical Trial Search block Test
A Phase 3, 2-part, Open-label Study to Evaluate the Safety and Pharmacokinetics of Lumacaftor/Ivacaftor in Subjects 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del
VX809_122_Infants
What is the goal of the study?
To learn more about this study, please email the study team member listed below.
Who can participate in the study?
Everyone